LT-CAGE TAPERED FUSION DEVICE

Intervertebral Fusion Device With Bone Graft, Lumbar

FDA Premarket Approval P970015 S020

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a revised laparoscopic surgical technique for implantation of the lt-cage. The device remains marketed under the trade name lt-cage tapered fusion device and is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level form l2-s1. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level. Lt-cage implants are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach. Patients receiving the lt-cage lumbar tapered fusion device should have had at least six months of nonoperative treatment prior treatment with the lt-cage.

DeviceLT-CAGE TAPERED FUSION DEVICE
Classification NameIntervertebral Fusion Device With Bone Graft, Lumbar
Generic NameIntervertebral Fusion Device With Bone Graft, Lumbar
ApplicantSOFAMOR DANEK
Date Received2002-04-04
Decision Date2002-08-12
PMAP970015
SupplementS020
Product CodeMAX
Advisory CommitteeOrthopedic
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SOFAMOR DANEK 1800 Pyramid Place memphis, TN 38132

Supplemental Filings

Supplement NumberDateSupplement Type
P970015Original Filing
S031 2005-01-28 Normal 180 Day Track No User Fee
S030 2004-11-15 Real-time Process
S029 2004-09-22 Real-time Process
S028 2004-07-01 30-day Notice
S027 2004-03-19 Special (immediate Track)
S026 2004-03-19 Special (immediate Track)
S025 2003-08-25 Normal 180 Day Track No User Fee
S024
S023
S022 2002-10-30 Normal 180 Day Track
S021 2002-10-25 Normal 180 Day Track No User Fee
S020 2002-04-04 Normal 180 Day Track
S019 2001-04-09 Normal 180 Day Track
S018
S017 2000-09-28 Normal 180 Day Track
S016
S015
S014 2000-05-23 Normal 180 Day Track
S013 2000-02-02 Normal 180 Day Track
S012
S011 1999-12-21 Normal 180 Day Track
S010 1999-11-24 Normal 180 Day Track
S009 1999-10-07 Normal 180 Day Track
S008 1999-10-06 Normal 180 Day Track
S007
S006
S005 1999-08-02 Real-time Process
S004
S003 1998-12-04 Normal 180 Day Track
S002 1998-09-09 Normal 180 Day Track
S001 1998-06-15 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
00673978955827 P970015 008
00673978955810 P970015 008
00673978957593 P970015 009
00673978957586 P970015 009
00613994618733 P970015 022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.